Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Hematology

Understanding Hemoglobin Lepore-Beta-Thalassemia Syndrome

At a Glance

Hemoglobin Lepore-beta-thalassemia syndrome results from an inherited fusion of two hemoglobin genes, reducing production of the beta part of hemoglobin. One-copy carriers often have mild or no symptoms, while other gene combinations can cause severe anemia, transfusions, and lifelong monitoring.

Hemoglobin Lepore (Hb Lepore) is a rare type of hemoglobin disorder that sits at the intersection of two categories: it is a structural variant (a change in the shape of the hemoglobin) and a form of thalassemia (a condition where the body doesn’t produce enough of a specific part of hemoglobin) [1][2]. While its name sounds unique, it behaves clinically like beta-thalassemia because it reduces the amount of functional “beta” protein your body can make [2].

The Genetic “Crossover”

To understand Hb Lepore, it helps to think of your genes as instructions. Your body uses two nearby genes—the delta gene and the beta gene—to make parts of your hemoglobin. In Hb Lepore, these two genes accidentally swap sections during a biological process called unequal crossover [1][2].

Instead of two separate, healthy genes, this swap creates a single fusion gene that is part delta and part beta [3]. This new fusion gene can make hemoglobin, but it does so very slowly and inefficiently. Because the body cannot produce enough of this fusion protein to make up for the missing beta protein, it results in the anemia seen in beta-thalassemia [2][3].

Types of Hb Lepore Variants

There are different structural variants of Hb Lepore based on exactly where the delta and beta genes fused. These are often named after the locations where they were first identified, though they are found across various populations worldwide:

  • Hb Lepore Boston-Washington: This is a common variant and has been identified in families from Europe, the Middle East, and Asia [4][5].
  • Hb Lepore Hollandia: This variant involves a slightly different fusion point and has been reported in families from the Indian subcontinent and Southeast Asia [6][7].
  • Hb Lepore Baltimore: Another recognized fusion point, though it is less commonly discussed in clinical literature [7].

The Spectrum of Severity

The impact of Hb Lepore on your health depends entirely on your genotype—how many copies of the variant you have and what other hemoglobin genes you inherited.

Hb Lepore Trait (Heterozygous)

Most people with Hb Lepore are “carriers,” meaning they have one Hb Lepore gene and one normal beta gene (heterozygous).

  • Symptoms: The trait is usually clinically mild. Carriers may have no symptoms at all, or they may experience mild anemia and fatigue [8].
  • Blood Findings: Your doctor will likely notice microcytosis (red blood cells that are smaller than average) [8][9]. It is important to know that this microcytosis is genetic and not automatically a sign of iron deficiency; iron supplements should only be taken if an actual iron deficiency is confirmed.
  • Identification: In a lab test, carriers typically have a measurable Hb Lepore fraction, often around 5% to 15%, though this varies [8].

Homozygous Hb Lepore

This occurs when you inherit an Hb Lepore gene from both parents.

  • Severity: This is a much more serious condition. The severity must be assessed individually, but it frequently resembles thalassemia major or thalassemia intermedia [1][9].
  • Symptoms: Significant anemia often begins in childhood, and many patients require regular blood transfusions to remain healthy [1].
  • Blood Findings: These patients usually have no normal “adult” hemoglobin (HbA). Instead, their blood is primarily made up of fetal hemoglobin (HbF) and a fraction of Hb Lepore [9].

Compound Heterozygous (Hb Lepore-Beta-Thalassemia)

This occurs when you inherit one Hb Lepore gene and one different beta-thalassemia mutation.

  • Severity: This is highly variable. Some people have a moderate form of anemia and may only need occasional transfusions, while others have a severe form requiring regular, lifelong transfusions [6][10].
  • Modifiers: Other genetic factors, such as inheriting an alpha-thalassemia trait at the same time, can sometimes modify the symptoms by slightly balancing out the protein production in your red blood cells, though this does not guarantee a mild course [10][11].

Understanding Your Diagnosis

It is important to distinguish between having the “trait” (being a carrier) and having the “syndrome” (homozygous or compound heterozygous). While carriers lead generally normal lives with mild laboratory abnormalities, those with the syndrome require specialized, lifelong care from a hematologist (blood specialist) to manage anemia and monitor for iron overload, a common complication [12][13]. Diagnosing the exact variant requires advanced molecular testing, as standard lab tests can mistake Hb Lepore for ordinary iron deficiency or standard beta-thalassemia [1][6].

Common questions in this guide

What is hemoglobin Lepore-beta-thalassemia syndrome?
It is an inherited hemoglobin disorder caused by a fusion of parts of the delta and beta genes. The fusion gene makes its protein inefficiently, so the body may produce too little functional beta hemoglobin and develop anemia. Severity depends on whether a person has one Hb Lepore gene, two, or an Hb Lepore gene plus a beta-thalassemia mutation.
Is Hb Lepore trait the same as the syndrome?
No. A person with one Hb Lepore gene and one normal beta gene usually has a mild carrier trait, often with small red blood cells and little or no anemia. Having an Hb Lepore gene from both parents, or one Hb Lepore gene plus a different beta-thalassemia mutation, can cause more significant anemia and may require transfusions.
How is Hb Lepore diagnosed and confirmed?
Blood testing may show small red blood cells, anemia, and an Hb Lepore fraction, but routine testing can resemble iron deficiency or typical beta-thalassemia. Molecular genetic testing can confirm the fusion gene and identify subtypes such as Boston-Washington, Hollandia, or Baltimore. A hematologist can interpret the genetic result with the rest of the blood findings.
Will I need regular blood transfusions for Hb Lepore?
It depends on your inherited gene combination and how severe your anemia is. Carriers usually do not need regular transfusions, while homozygous or compound forms may require occasional or lifelong regular transfusions. Your hematologist can determine whether the condition is transfusion-dependent or non-transfusion-dependent.
Does having small red blood cells mean I need iron supplements?
Not necessarily. In Hb Lepore trait, microcytosis is often caused by the inherited hemoglobin variant and does not automatically mean iron deficiency. Iron supplements should be used only when testing confirms iron deficiency, while people receiving transfusions need monitoring for iron overload.
Can alpha-thalassemia change the severity of Hb Lepore?
Yes, inheriting alpha-thalassemia at the same time may modify the balance of hemoglobin production and sometimes lessen symptoms. It does not guarantee a mild course, so severity still needs to be assessed from blood tests and genotype.
What genetic testing should be considered before having children?
Ask a clinician about confirming your Hb Lepore subtype and testing your partner for Hb Lepore and other beta-thalassemia variants. The results can help estimate the chance that a child will inherit a clinically significant hemoglobin disorder. A hematologist or genetics professional can explain what the findings mean for your family.

Get notified when new evidence is published on Hemoglobin Lepore-beta-thalassemia syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (13)
  1. 1

    Homozygous Hemoglobin Lepore: A Rare Condition Seen in a Bangladeshi Family.

    Aziz MA, Khan WA, Das SA, Banu B

    Mymensingh medical journal : MMJ 2021; (30(4)):1172-1176.

    PMID: 34605493
  2. 2

    Biochemical and Molecular Analysis of the Hb Lepore Boston Washington in a Syrian Homozygous Child.

    Pirastru M, Manca L, Trova S, Mereu P

    BioMed research international 2017; (2017()):1261972 doi:10.1155/2017/1261972.

    PMID: 28553644
  3. 3

    Homozygous Lepore Syndrome: A case report.

    Bhusal A, Bhandari S, Seth T, Sah RP

    Annals of medicine and surgery (2012) 2022; (80()):104168 doi:10.1016/j.amsu.2022.104168.

    PMID: 36045803
  4. 4

    Molecular characterization of similar Hb Lepore Boston-Washington in four Chinese families using third generation sequencing.

    Zhuang J, Zhang N, Zheng Y, et al.

    Scientific reports 2024; (14(1)):9966 doi:10.1038/s41598-024-60604-7.

    PMID: 38693200
  5. 5

    The Relevance of β-Thalassemia Heterozygosity in Pediatric Clinical Practice: Croatian Experience.

    Dordevic A, Ugrin M, Sutic IM, et al.

    Children (Basel, Switzerland) 2024; (11(7)) doi:10.3390/children11070785.

    PMID: 39062234
  6. 6

    β-Thalassemia Intermedia Caused by Compound Heterozygosity for Hb Lepore-Hollandia and β-Thalassemia is Rare in the Indian Population.

    Sreedharanunni S, Chhabra S, Hira JK, et al.

    Hemoglobin 2015; (39(5)):362-5 doi:10.3109/03630269.2015.1064004.

    PMID: 26291970
  7. 7

    Molecular Characteristics of Hb New York [β113(G15)Val→Glu, HBB: c.341T>A] in Thailand.

    Chaibunruang A, Singha K, Srivorakun H, et al.

    Hemoglobin 2018; (42(1)):11-15 doi:10.1080/03630269.2018.1430586.

    PMID: 29464999
  8. 8

    Rare occurrence of hemoglobin Lepore variant in a Palestinian patient: a case report and brief literature review.

    Asees MY, Shrateh ON, Jobran AWM, Assi AS

    Annals of medicine and surgery (2012) 2023; (85(10)):5219-5222 doi:10.1097/MS9.0000000000001212.

    PMID: 37811104
  9. 9

    Corpuscular Haemolytic Anaemias - Lepore Haemoglobinopathy.

    Tudorascu I, Neamtu S, Stanca L, et al.

    Current health sciences journal 2014; (40(4)):281-4 doi:10.12865/CHSJ.40.04.10.

    PMID: 26793325
  10. 10

    Molecular and clinical analysis of haemoglobin Lepore in Campania, a region of Southern Italy.

    Ricchi P, Ammirabile M, Spasiano A, et al.

    Hematology (Amsterdam, Netherlands) 2017; (22(7)):437-443 doi:10.1080/10245332.2017.1289304.

    PMID: 28218017
  11. 11

    [Clinical Diagnosis and Prenatal Screening of Hb Lepore-BW Associated with IVS-II-654 Heterozygous Mutation].

    Bai HL, Cheng W, Cui J, et al.

    Zhongguo shi yan xue ye xue za zhi 2022; (30(2)):529-533 doi:10.19746/j.cnki.issn.1009-2137.2022.02.034.

    PMID: 35395991
  12. 12

    Non-transfusion-dependent thalassemia and thalassemia intermedia: epidemiology, complications, and management.

    Vichinsky E

    Current medical research and opinion 2016; (32(1)):191-204 doi:10.1185/03007995.2015.1110128.

    PMID: 26479125
  13. 13

    Alpha- and Beta-thalassemia: Rapid Evidence Review.

    Baird DC, Batten SH, Sparks SK

    American family physician 2022; (105(3)):272-280.

    PMID: 35289581

This page is for informational purposes only and does not constitute medical advice. Your hematologist or genetics professional should interpret your genotype, anemia, transfusion needs, and iron levels.